A5024431945- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Aortic Disease and Treatment Approaches
- Vascular Procedures and Complications
- Cardiac Valve Diseases and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac Structural Anomalies and Repair
- Aortic aneurysm repair treatments
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Central Venous Catheters and Hemodialysis
- Peripheral Artery Disease Management
- Congenital Heart Disease Studies
- Infective Endocarditis Diagnosis and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Mechanical Circulatory Support Devices
- Innovation Policy and R&D
- Advanced X-ray and CT Imaging
- Tracheal and airway disorders
- Diabetes Treatment and Management
- Advanced MRI Techniques and Applications
- Coronary Artery Anomalies
- Cardiac electrophysiology and arrhythmias
Instituto Nacional de Cardiología
2013-2024
Centro Médico ABC
2021-2024
Universidad Panamericana
2023
Instituto Nacional de Cardiologia
2010-2020
University of Coimbra
2007-2013
Objectives To evaluate the mid‐term outcomes, and aortic remodeling in Marfan syndrome (MFS) patients with type B dissection that were treated endovascular repair. Background MFS is a relative contraindication to thoracic repair (TEVAR). Mid‐term outcomes data after TEVAR are limited, occurrence of late events remains unclear. Methods Of 89 underwent between September 2002 February 2011, 10 follow‐up fulfilled Ghent criteria for complicated dissection. High risk open surgery was documented...
Abstract Objectives To report clinical, angiographic characteristics, outcomes, and predictors of unsuccessful procedures in patients who underwent chronic total occlusion (CTO) percutaneous coronary interventions (PCI) Latin America. Background CTO PCI has been increasingly performed worldwide, but there is a lack information this region. Methods An international multicenter registry was developed to collect data on centers Patient, angiographic, procedural outcome were evaluated....
Abstract Background Guide catheter extensions (GCEs) increase support and facilitate equipment delivery, but aggressive instrumentation may be associated with a higher risk of complications. Aim Our aim was to assess the impact GCEs on procedural success complications in patients submitted chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Methods We analyzed data from multicenter LATAM CTO Registry. Procedural defined as <30% residual stenosis TIMI 3 distal flow....
To evaluate the outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in patients with and without prior artery bypass graft (CABG) surgery.Data on CTO PCI versus CABG remains limited scarce representation from developing regions like Latin America.We evaluated undergoing 42 centers participating LATAM registry between 2008 2020. Statistical analyses were stratified according to status. The interest technical procedural success in-hospital major adverse cardiac...
Venovenous extracorporeal membrane oxygenation (ECMO) has become a rescue therapy for acute respiratory distress syndrome (ARDS) secondary to COVID-19 patients who are refractory conventional therapy. However, this comes with complications, and alternative cannulation strategies needed overcome these difficulties. In article, we present case of venovenous ECMO presenting hypoxemia right ventricular dysfunction, which were corrected by cannulating the pulmonary artery. This situation is...
In recent years, transcatheter aortic valve replace (TAVR) has revolutionized the interventional treatment of stenosis, however, only scarce evidence considers it as for Aortic Regurgitation (AR). At present, Pure AR Native Valve with TAVR does not fall within recommendations international guidelines, poses multiple challenges immediate and long-term variable unpredictable results. The objective this paper is to present case a patient prohibitive operative risk that benefited AR.
TIMI 2-3 estable.